Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.
about
The periodic health examination: 2. 1984 update. Canadian Task Force on the Periodic Health ExaminationThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsHepatitis B in pregnancy.Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisationMaternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.Hepatitis B Therapy in PregnancyA program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women.Epidemiology of hepatitis B infection in the Western Pacific and South East AsiaImmunisation against hepatitis B in Taiwan.Prevalence of hepatitis B virus infection in pregnant women in the Montreal area.Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trialsPerinatal transmission of hepatitis B in Northern Ireland.Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria.Perinatal transmission of hepatitis B.Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.Immunisation of neonates at high risk of hepatitis B in England and Wales: national surveillance.Perinatal transmission of hepatitis B virus.Hepatitis B viral markers in pregnant women and newborn infants in Korea.Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is PregnantAntiviral therapy: current concepts and practicesDeficient knowledge on hepatitis B infection in pregnant women and prevalence of hepatitis B surface antigen carriage in an endemic area: a review.Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasCost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicitySequence of events in natural infection of Pekin duck embryos with duck hepatitis B virusAcute hepatic failure in children.Medical virology of hepatitis B: how it began and where we are nowChild-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients.Micromodification of Serodia HBe haemagglutination kit and modification of kit to test for anti-HBeGender specific medicine in liver diseases: a point of view.Viral dynamics in hepatitis B virus infection.Immunisation of infants at high risk of hepatitis B.Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
P2860
Q24548741-5B5393A9-06DD-4D94-A312-8535A175CEA1Q28073299-7D4B0DE7-9AD5-429B-BC30-5C69AD9E54C0Q33617002-7F657E8F-3A2F-4CC1-9DFF-417626E2E739Q33642229-046BABA5-8F56-45F9-9506-9270452C90E1Q33655929-2717D0C3-A853-4EBC-900B-25EA5530123CQ34154952-C2ADD13E-ADF5-4790-8563-9C7B72288AE8Q34195174-EED81F93-589B-4DF2-AE3C-C53DFB75F7CAQ34441984-EB51CEB6-42E9-4602-A8DB-EB20695D76F0Q34442054-189F24B9-73A0-47CA-942F-BFD0D621B038Q34727754-43600959-5A3B-4668-BF94-0A93F24ECF4CQ34979125-A9F73338-6384-4926-9B26-1C2BC855A73DQ34990602-5F9C693D-D49D-4D20-B5E3-88D01AB76293Q35059029-EE0C0A01-14C1-414F-868D-F3D0FA3C0A7BQ35118439-CA53F16D-D649-4D09-AB60-4047AC7CA8C4Q35540731-6E387567-58D0-4EF3-A900-C4D1CA4ED036Q35701191-8329CCB6-608F-4048-9EED-B5D23F515447Q35805799-DE151DBA-D201-4372-AF9F-1A383BE76B2DQ35948380-D7EA81B1-4836-4A97-AFEF-4AB714B91F22Q35999165-C2303F19-EC92-458C-AAF9-29F4652E0DEBQ36070394-62C7C5FC-5A2E-467D-B69F-93557404FC51Q36302573-D8CBE095-705E-4016-B7EB-BAEA9A9A3F78Q36504737-A1342BFF-F632-41B6-A1F8-1006681EB0CDQ36669473-AF6F7A5C-810A-491C-B7D0-312188FB7BBFQ36902544-C4A538A2-32D8-4503-B8AC-9215F3BC3EFDQ36988740-96E0E205-C115-49A5-BDB1-1518640540CBQ37059714-949531DE-65F8-4130-91AD-BBB651D9BC57Q37174187-3A0C7C4D-2B64-47AC-82A9-1F5D2F6FEF9AQ37203492-C807046C-9DC2-450F-AE15-5A6E4185202CQ37617937-024F1704-E4A2-4529-A92F-6BF2044E8A4CQ37638400-C4FBDA03-E8D9-47FD-A6FA-AA2F28CCF857Q42332133-2E771B75-71F3-4456-AC16-6F70ACA3A003Q42878698-E67D5AD6-3343-48B0-9EC9-6763AE78A648
P2860
Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Hepatitis B immune globulin (H ...... lind placebo-controlled trial.
@en
type
label
Hepatitis B immune globulin (H ...... lind placebo-controlled trial.
@en
prefLabel
Hepatitis B immune globulin (H ...... lind placebo-controlled trial.
@en
P2093
P1433
P1476
Hepatitis B immune globulin (H ...... blind placebo-controlled trial
@en
P2093
C E Stevens
R P Beasley
W Szmuness
P304
P356
10.1016/S0140-6736(81)90832-1
P407
P577
1981-08-01T00:00:00Z